Perspectives on the Treatment of Malignant Pleural Mesothelioma
Year: 2021
Type: review
Abstract: Most mesotheliomas originate in the pleura and are due to asbestos exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality remains high in part because of late diagnosis and treatment resistance. Pemetrexed–cisplatin and immune checkpoint inhibitors modestly extend survival.
Source: New England Journal of Medicine
Authors: Sam M. Janes, Doraid Alrifai, Dean A. Fennell
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Medical Research Council
Award: MSCTRAIL for lung cancer
OpenAlex ID: W3201306276
